In conclusion, our study sheds light on the impact of LRRK2-mediated neuroinflammation on neurons in a context related to PD and AD and, importantly, suggests that targeting LRRK2 activity could be protective and beneficial for brain disorders with an inflammatory component. The gene discussed is LRRK2; the disease is brain disorder.